Mobile-health Network Solutions Unveils Proprietary Phi GPT, AI-Powered Health Companion
Mobile-health Network Solutions (NASDAQ: MNDR) has launched Phi GPT, a proprietary AI engine powering its new health companion Aiko within the company's Health Operating System. The AI-powered companion provides personalized healthcare guidance while maintaining strict data privacy through its closed ecosystem architecture.
Early user feedback shows strong adoption metrics: 70% of users value empathetic interactions, 65% prefer simple interfaces, and 80% seek personalized advice. The company is targeting a $660B+ global digital health market, with AI healthcare market growing at >35% CAGR.
The rollout began yesterday with limited users, expanding to all Singapore users within two weeks and global users within a month.
Mobile-health Network Solutions (NASDAQ: MNDR) ha lanciato Phi GPT, un motore AI proprietario che alimenta il suo nuovo accompagnatore sanitario Aiko all'interno del Health Operating System dell'azienda. L'accompagnatore alimentato dall'IA offre indicazioni personalizzate per la salute mantenendo alti standard di privacy dei dati tramite la sua architettura a ecosistema chiuso.
Il feedback iniziale degli utenti mostra metriche di adozione significative: 70% degli utenti apprezza interazioni empatiche, 65% preferisce interfacce semplici e 80% cerca consigli personalizzati. L'azienda punta a un mercato globale della salute digitale superiore a $660B+, con il mercato IA in sanità in crescita a >35% CAGR.
Il rollout è iniziato ieri con un numero limitato di utenti, espandendosi a tutti gli utenti di Singapore entro due settimane e agli utenti globali entro un mese.
Mobile-health Network Solutions (NASDAQ: MNDR) ha lanzado Phi GPT, un motor de IA propio que impulsa su nuevo compañero de salud Aiko dentro del Health Operating System de la empresa. El compañero impulsado por IA ofrece orientación personalizada de salud manteniendo una estricta privacidad de datos a través de su arquitectura de ecosistema cerrado.
Los primeros comentarios de los usuarios muestran métricas de adopción sólidas: el 70% de los usuarios valora las interacciones empáticas, el 65% prefiere interfaces simples y el 80% busca asesoramiento personalizado. La empresa apunta a un mercado global de salud digital de más de $660B+, con el mercado de IA en salud creciendo a una tasa anual compuesta superior al >35% CAGR.
El despliegue comenzó ayer con usuarios limitados, expandiéndose a todos los usuarios de Singapur en dos semanas y a usuarios globales en un mes.
Mobile-health Network Solutions (NASDAQ: MNDR)가 Phi GPT를 출시했습니다. 이는 회사의 Health Operating System 내 새로운 건강 동반자 Aiko를 구동하는 독점 AI 엔진입니다. AI로 구동되는 이 동반자는 폐쇄형 생태계 아키텍처를 통해 엄격한 데이터 프라이버시를 유지하면서 개인화된 건강 관리 지침을 제공합니다.
초기 사용자 피드백은 강력한 채택 지표를 보여줍니다: 70%의 사용자가 공감적 상호작용을 가치 있게 여기고, 65%가 단순한 인터페이스를 선호하며, 80%가 개인화된 조언을 찾습니다. 회사는 글로벌 디지털 헬스 시장이 $660B+를 넘을 것으로 보고 있으며, AI 헬스케어 시장은 >35% CAGR로 성장하고 있습니다.
전개는 어제 제한된 사용자로 시작되었고, 2주 내에 싱가포르의 모든 사용자로, 1개월 내에 전 세계 사용자로 확장될 예정입니다.
Mobile-health Network Solutions (NASDAQ: MNDR) a lancé , un moteur IA propriétaire alimentant son nouvel assistant santé Aiko au sein du Health Operating System de l'entreprise. L'assistant alimenté par l'IA fournit des conseils personnalisés en matière de santé tout en garantissant une confidentialité stricte des données grâce à son architecture fermée en écosystème.
Les premiers retours des utilisateurs montrent des métriques d'adoption solides : 70% des utilisateurs apprécient les interactions empathiques, 65% préfèrent des interfaces simples et 80% recherchent des conseils personnalisés. L'entreprise vise un marché mondial de la santé digitale supérieur à $660B+, le marché IA en santé croissant à un >35% CAGR.
Le déploiement a commencé hier avec un nombre limité d'utilisateurs, s'étendant à tous les utilisateurs de Singapour sous deux semaines et aux utilisateurs mondiaux sous un mois.
Mobile-health Network Solutions (NASDAQ: MNDR) hat Phi GPT gestartet, eine firmeneigene KI-Engine, die seinen neuen Gesundheitsbegleiter Aiko im Health Operating System des Unternehmens antreibt. Der KI-gesteuerte Begleiter bietet personalisierte Gesundheitsberatung, während er strenge Datenschutzbestimmungen durch seine geschlossene Ökosystem-Architektur einhält.
Frühes Nutzer-Feedback zeigt starke Adoptionsmetriken: 70% der Nutzer schätzen empathische Interaktionen, 65% bevorzugen einfache Oberflächen, und 80% suchen nach personalisierter Beratung. Das Unternehmen zielt auf einen globalen digitalen Gesundheitsmarkt von über $660B+, wobei der AI-Gesundheitsmarkt mit einem CAGR von >35% wächst.
Der Rollout begann gestern mit einer begrenzten Nutzerbasis, erweitert sich innerhalb von zwei Wochen auf alle Singapur-Nutzer und innerhalb eines Monats auf globale Nutzer.
Mobile-health Network Solutions (ش.م.م) المدرجة في ناسداك MNDR قد أطلقت Phi GPT، محرك ذكاء اصطناعي مملوك يدعم رفيقتها الصحية الجديدة Aiko ضمن نظام التشغيل الصحي للشركة. يوفر الرفيق المدعوم بالذكاء الاصطناعي إرشادات رعاية صحية شخصية مع الحفاظ على خصوصية البيانات من خلال بنية النظام البيئي المغلقة.
تعكس تعليقات المستخدمين المبكرة تبنيًا قويًا: 70% من المستخدمين يقدّرون التفاعل التعاطفي، و65% يفضلون واجهات بسيطة، و80% يبحثون عن نصائح مخصصة. تستهدف الشركة سوق الصحة الرقمية العالمي البالغ $660B+، مع نمو سوق الذكاء الاصطناعي الصحي بمعدل نمو سنوي مركب يتجاوز >35%.
بدأ التوسع بالأمس مع عدد محدود من المستخدمين، على أن يتم توسيعه ليشمل جميع مستخدمي سنغافورة خلال أسبوعين وبالعالمية خلال شهر.
Mobile-health Network Solutions (NASDAQ: MNDR) 已推出 Phi GPT，这是一款专有的 AI 引擎，为公司 Health Operating System 内的全新健康助手 Aiko 提供动力。该 AI 驱动的助手在其封闭生态系统架构下提供个性化的医疗保健指导，同时严格的数据隐私保护。
早期用户反馈显示强劲的采用率：70% 的用户重视有同理心的互动，65% 偏好简单界面，80% 寻求个性化建议。公司目标是全球数字健康市场超过 $660B+，AI 医疗市场以超过 35% 的 CAGR 增长。
rollout 昨天开始，有限用户测试，预计两周内扩展到新加坡所有用户，一个月内扩展到全球用户。
- Proprietary in-house AI development reduces costs and dependency on third-party providers
- Strong early user feedback with 70-80% positive reception across key metrics
- Targeting massive market opportunity of $660B+ in global digital health
- Multiple revenue streams through teleconsults, chronic care, diagnostics, and future licensing
- Limited initial rollout may impact immediate revenue potential
- Operating in highly competitive AI healthcare market
Insights
MNDR launches proprietary AI health companion that could strengthen all revenue streams while maintaining data privacy and reducing costs.
MNDR's launch of Phi GPT represents a significant strategic move that addresses several critical challenges in digital healthcare simultaneously. By developing this proprietary AI in-house rather than relying on external providers, the company has created a closed ecosystem that substantially reduces third-party dependencies and associated data privacy risks – a paramount concern in healthcare applications.
The companion application Aiko serves as the user-facing interface of this technology, focusing on empathetic, multilingual interactions that could drive adoption among diverse demographics, including vulnerable populations like the elderly. Early user feedback citing 70% preference for empathetic interactions and 80% seeking personalized advice suggests product-market fit in its initial deployment.
The monetization strategy is particularly noteworthy as it creates multiple revenue touchpoints: teleconsult conversion, chronic care subscriptions, pharmaceutical and diagnostic services, and potential future IoT integrations. This multi-stream approach positions MNDR to capture value across the healthcare journey rather than from isolated transactions.
From a competitive standpoint, developing proprietary AI rather than licensing existing models provides MNDR with cost advantages and differentiation in the rapidly growing $40B+ AI healthcare market. The reduction in dependency on external AI services should improve margins while the enhanced privacy features address a key adoption barrier in healthcare technology.
The phased rollout strategy – starting in Singapore before expanding globally – allows for controlled scaling and iterative improvements based on user feedback, reducing implementation risks for this technology.
Singapore, Singapore--(Newsfile Corp. - September 30, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced the launch of Phi GPT, an AI engine developed exclusively for clinical care pathways and powers a closed-ecosystem health companion built into the Company's Health Operating System (HOS).
Unlike platforms that depend on external AI providers, this companion - named Aiko - is primarily backed by proprietary, end-to-end integration, with core AI developed in-house and operating exclusively within MNDR's ecosystem, ensuring minimal reliance on third-party AI, data sharing, or outside integrations.
As a result, patient queries with Aiko - on such matters as medication adherence, preventive measures, and general health - remain private; never shared externally, visible to other users, or used to train outside models.
Via its access to secure patient data, Aiko consistently provides users with safe, accurate, warm, and empathetic step-by-step guidance tailored to each patient's needs - including patients who are unwell, elderly, or overwhelmed.
Aiko is also multilingual and simple to use, supporting multiple languages and underserved communities across Southeast Asia and multiple global markets.
"With Phi GPT powering Aiko, we are uniting science and empathy into a single lifelong health companion," said Co-CEO Dr. Siaw Tung Yeng. "Patients will know Aiko as a trusted guide, while investors may soon witness Phi GPT as a proprietary, scalable AI engine likely to strengthen every revenue stream in MNDR's ecosystem."
MNDR's ownership and operation of Phi GPT, he added, reduces its costs and boosts its scalability.
Early feedback, he stated, from MNDR's user base indicates that Aiko's primary features are being well received. 70 percent of the companion's users reported that they prioritize empathetic, human-like interactions, while 65 percent said they want simple interfaces, and 80 percent seek personalized advice.
Market Opportunity:
- Global Digital Health Market (2025E):
$660B + - AI in Healthcare Market (2025E):
$40B +, >35% CAGR - Primary Care & Teleconsults (Southeast Asia and United States focus):
$200B +
Monetization Pathways:
- Teleconsult Conversion
- Chronic Care Subscriptions
- Pharma & Diagnostics
- Future IoT Integrations
- Selective B2B Licensing
"MNDR's mission is bold but clear: to make healthcare as simple and natural as talking to a trusted friend," said Dr. Siaw. "With Phi GPT as its core and Aiko as its human-like companion, MNDR is building a fully integrated Health Operating System that will deliver telemedicine, diagnostics, and IoT care from cradle to grave, across Southeast Asia and beyond."
Dr. Siaw said the launch of Phi GPT, which began yesterday to a limited number of users, will be rolled out to all users in Singapore within the next two weeks and to all global users within the next month.
About Mobile-health Network Solutions
Mobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website.
Forward-Looking Statements
Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.
For media inquiries, please contact:
Mobile-health Network Solutions Investor Relations Contact:
2 Venture Drive, #07-06/07 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.com
Investor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: info@skylineccg.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268514
FAQ
What is MNDR's Phi GPT and how does it differ from other healthcare AI?
What are the key features of MNDR's Aiko health companion?
What is the market size for MNDR's digital health solutions?
When will MNDR's Phi GPT be available to users?
How does MNDR plan to monetize Phi GPT and Aiko?
